Rodenburg Michaela, Fischer Meike, Engelmann Afra, Harbers Stephanie O, Ziegler Marion, Löhler Jürgen, Stocking Carol
Heinrich-Pette-Institut, Hamburg, Germany.
J Virol. 2007 Jan;81(2):732-42. doi: 10.1128/JVI.01430-06. Epub 2006 Nov 1.
Murine leukemia viruses (MuLV) induce leukemia through a multistage process, a critical step being the activation of oncogenes through provirus integration. Transcription elements within the long terminal repeats (LTR) are prime determinants of cell lineage specificity; however, the influence of other factors, including the Env protein that modulates cell tropism through receptor recognition, has not been rigorously addressed. The ability of 10A1-MuLV to use both PiT1 and PiT2 receptors has been implicated in its induction of blast cell leukemia. Here we show that restricting receptor usage of 10A1-MuLV to PiT2 results in loss of blast cell transformation capacity. However, the pathogenicity was unaltered when the env gene is exchanged with Moloney MuLV, which uses the Cat1 receptor. Significantly, the leukemic blasts express erythroid markers and consistently contain proviral integrations in the Fli1 locus, a target of Friend MuLV (F-MuLV) during erythroleukemia induction. Furthermore, an NB-tropic variant of 10A1 was unable to induce blast cell leukemia in C57BL/6 mice, which are also resistant to F-MuLV transformation. We propose that 10A1- and F-MuLV actually induce identical (erythro)blastic leukemia by a mechanism involving Fli1 activation and cooperation with inherent genetic mutations in susceptible mouse strains. Furthermore, we demonstrate that deletion of the Icsbp tumor suppressor gene in C57BL/6 mice is sufficient to confer susceptibility to 10A1-MuLV leukemia induction but with altered specificity. In summary, we validate the significance of the env gene in leukemia specificity and underline the importance of a complex interplay of cooperating oncogenes and/or tumor suppressors in determining the pathogenicity of MuLV variants.
鼠白血病病毒(MuLV)通过多阶段过程诱发白血病,关键步骤是通过前病毒整合激活癌基因。长末端重复序列(LTR)中的转录元件是细胞谱系特异性的主要决定因素;然而,包括通过受体识别调节细胞嗜性的Env蛋白在内的其他因素的影响尚未得到严格研究。10A1-MuLV使用PiT1和PiT2受体的能力与其诱发原始细胞白血病有关。在此我们表明,将10A1-MuLV的受体使用限制为PiT2会导致原始细胞转化能力丧失。然而,当env基因与使用Cat1受体的莫洛尼MuLV交换时,致病性未改变。值得注意的是,白血病原始细胞表达红系标志物,并且在Fli1基因座中始终含有前病毒整合,Fli1基因座是Friend MuLV(F-MuLV)在红白血病诱导过程中的一个靶点。此外,10A1的一种嗜NB变体在C57BL/6小鼠中无法诱发原始细胞白血病,C57BL/6小鼠也对F-MuLV转化具有抗性。我们提出,10A1-MuLV和F-MuLV实际上通过涉及Fli1激活以及与易感小鼠品系中固有基因突变协同作用的机制诱发相同的(红系)原始细胞白血病。此外,我们证明,C57BL/6小鼠中Icsbp肿瘤抑制基因的缺失足以使其对10A1-MuLV白血病诱导易感,但特异性发生改变。总之,我们验证了env基因在白血病特异性中的重要性,并强调了协同作用的癌基因和/或肿瘤抑制因子之间复杂相互作用在确定MuLV变体致病性方面的重要性。